Publication | Open Access

Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression

UrologyHormonal ReceptorNf-kappa BTumor SuppressorProstatic DiseaseAnti-androgen TreatmentMedicineCell BiologyAndrogen Receptor-variant ExpressionEndocrine-related Cancer